» Articles » PMID: 33519531

Calcium-Sensing Receptor Participates in High Glucose-Induced EndMT in Primary Human Aortic Endothelial Cells

Overview
Journal Front Physiol
Date 2021 Feb 1
PMID 33519531
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Previous studies have shown that high glucose (HG) induces endothelial cell (EC) damage via endothelial-to-mesenchymal transition (EndMT). Although the underlying mechanisms are still unclear, recent studies have demonstrated the role of calcium-sensing receptor (CaSR) in mediating EC damage. Therefore, the aim of our study was to investigate whether CaSR mediates HG-induced EndMT and to determine the underlying mechanism.

Methods: Bioinformatics analysis of microarray profiles (GSE30780) and protein-protein interaction (PPI) analyses were performed to select the hub genes. As for research, the human aortic ECs (HAECs) were exposed to HG to induce EndMT. The expression of CaSR and β-catenin was determined, as well as their effects on EndMT (endothelial marker CD31, mesenchymal marker FSP1, and α-SMA).

Results: The bioinformatics analysis indicated CaSR was significantly increased in HG-treated HAECs and was one of the hub genes. The results showed that HG significantly inhibited the expression of CD31 and increased FSP1 and α-SMA in a concentration- and time-dependent manner. Moreover, CaSR was increased in HAECs after HG treatment. The CaSR antagonist attenuated HG-induced expression of EndMT-related markers. Furthermore, HG treatment increased the nuclear translocation of β-catenin in HAECs. In contrast, blocking the nuclear translocation of β-catenin by DKK1 could attenuate HG-induced EndMT (increased the protein expression of CD31 by 30% and decreased the protein expression of FSP1 by 15% and α-SMA by 25%). CaSR siRNA further inhibited the HG-induced nuclear translocation of β-catenin in HAECs.

Conclusion: Our research demonstrated that HG-induced EndMT in HAECs might be mediated by CaSR and the downstream nuclear translocation of β-catenin.

Citing Articles

Epi-revolution in rheumatology: the potential of histone deacetylase inhibitors for targeted rheumatoid arthritis intervention.

Pai P, Vijeev A, Phadke S, Shetty M, Sundara B Inflammopharmacology. 2024; 32(4):2109-2123.

PMID: 38714604 PMC: 11300544. DOI: 10.1007/s10787-024-01486-z.


Experimental Models to Study Endothelial to Mesenchymal Transition in Myocardial Fibrosis and Cardiovascular Diseases.

Mimouni M, Lajoix A, Desmetz C Int J Mol Sci. 2024; 25(1).

PMID: 38203553 PMC: 10779210. DOI: 10.3390/ijms25010382.


METTL3 Promotes Endothelium-Mesenchymal Transition of Pulmonary Artery Endothelial Cells by Regulating TRPC6/Calcineurin/NFAT Signaling Pathways.

Kong C, Zhang F, Hu R, Wang L Evid Based Complement Alternat Med. 2023; 2023:8269356.

PMID: 36865750 PMC: 9974285. DOI: 10.1155/2023/8269356.

References
1.
Zhao W, Zhang Z, Zheng L, You C, Chi H, Zhang T . Calcium-sensing receptor activating ERK1/2 and PI3K-Akt pathways to induce the proliferation of osteosarcoma cells. Clin Exp Pharmacol Physiol. 2019; 47(3):517-519. DOI: 10.1111/1440-1681.13209. View

2.
Bhagavathula N, Hanosh A, Nerusu K, Appelman H, Chakrabarty S, Varani J . Regulation of E-cadherin and beta-catenin by Ca2+ in colon carcinoma is dependent on calcium-sensing receptor expression and function. Int J Cancer. 2007; 121(7):1455-62. DOI: 10.1002/ijc.22858. View

3.
McCrea P, Maher M, Gottardi C . Nuclear signaling from cadherin adhesion complexes. Curr Top Dev Biol. 2015; 112:129-96. PMC: 4410048. DOI: 10.1016/bs.ctdb.2014.11.018. View

4.
Fiorentino T, Prioletta A, Zuo P, Folli F . Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des. 2013; 19(32):5695-703. DOI: 10.2174/1381612811319320005. View

5.
Geng H, Guan J . MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway. Biochem Biophys Res Commun. 2017; 491(2):329-336. DOI: 10.1016/j.bbrc.2017.07.101. View